Related Experiment Video
Updated: Jun 29, 2026
09:20
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
3.7K
PP2Ac knockdown attenuates lipotoxicity‑induced pancreatic β‑cell dysfunction and apoptosis
Zhengwei Zhang1, Beier Tong1, Jie Liu1
1Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Experimental and Therapeutic Medicine
|November 6, 2023
Summary
Reducing protein phosphatase 2A catalytic subunit (PP2Ac) protects pancreatic beta cells from lipotoxicity. This study shows PP2Ac knockdown enhances cell resistance, improves insulin secretion, and offers insights for type 2 diabetes treatment.
Area of Science:
- Cell Biology
- Metabolic Diseases
- Molecular Endocrinology
Background:
- Protein phosphatase 2A (PP2A), a key serine/threonine phosphatase, regulates critical cellular processes including signaling, metabolism, and apoptosis.
- The catalytic subunit of PP2A (PP2Ac) is crucial for its function, yet its role in pancreatic beta-cells under lipotoxic conditions remains underexplored.
- Lipotoxicity significantly impairs pancreatic beta-cell function, contributing to the pathogenesis of type 2 diabetes mellitus.
Purpose of the Study:
- To investigate the regulatory role of PP2Ac in pancreatic beta-cells during lipotoxicity.
- To elucidate the protective mechanisms of PP2Ac knockdown against lipotoxicity in vitro and in vivo.
- To explore the potential of targeting PP2Ac for type 2 diabetes mellitus treatment.
Main Methods:
- Established lipotoxicity models using MIN6 cells and mice fed a high-fat diet (HFD).
- Utilized short hairpin RNAs and adeno-associated viruses for PP2Ac knockdown.
- Assessed cell viability, apoptosis, insulin secretion, oxidative stress, endoplasmic reticulum/mitochondrial function, and the MAPK pathway using various assays and western blotting.
Main Results:
- PP2Ac knockdown inhibited PP2A hyperactivation, enhanced beta-cell resistance to lipotoxicity, and reduced palmitate-induced apoptosis in MIN6 cells.
- PP2Ac knockdown protected endoplasmic reticulum and mitochondria, ameliorated insulin secretion, and suggested MAPK pathway involvement.
- In vivo studies demonstrated that PP2Ac knockdown attenuated HFD-induced insulin resistance and reduced compensatory beta-cell proliferation.
Conclusions:
- Interfering with PP2Ac gene expression offers significant protection to pancreatic beta-cells against lipotoxicity both in vitro and in vivo.
- The protective effects are mediated through mechanisms involving the MAPK pathway, improved insulin secretion, and enhanced beta-cell resilience.
- Targeting PP2Ac presents a promising therapeutic strategy for managing type 2 diabetes mellitus.
Related Concept Videos
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...